Публикации

2019 год

​

1. Baykov S., Tarasenko M., Zelenkov L. E., Kasatkina S., Savko P., Shetnev A. Diastereoselective Opening of Bridged Anhydrides by Amidoximes Providing Access to 1,2,4-Oxadiazole/Norborna(e)ne Hybrids. Eur. J. Org. Chem., 2019, 5685–5693. (IF 3.029) 

2. Shetnev A., Shlenev R., Efimova J., Ivanovskii S., Tarasov A., Petzer A., Petzer J. P. 1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B. Bioorganic & medicinal chemistry letters, 2019, 29(21), 126677. (IF 2.44) 

3. Filimonov S.I., Chirkova Z.V., Kabanova M.V., Makarova E.S., Shetnev A.A., Panova V.A. A Condensation of Biginelli products with 1,3-benzenediols: a facile access to diastereomerically pure hexahydro-5H-chromeno[4,3-d]pyrimidin-5-ones. Chemistry Select, 2019, 4 (33), 9550-9555. (IF 1.716) 

4. Михердов А. С., Байков С. В., Проскурина И. К., Шетнев А. Котов А.Д. Получение и свойства C,N-хелатных карбеновых комплексов палладия(II) c 2-аминобензо[d]тиазольным фрагментом. Журнал общей химии, 2019, 89, 10, 1572-1579. (IF 0.675) 

5. Panova V.A., Korsakov M.K., Shetnev A.A., Filimonov S.I. Synthesis of Substituted 5-hydroxypyrazolo[1,5-a]quinoxalin-4-ones. Mendeleev Communications, 2019, 29 (1), 114-115. (IF 2.01)

6. Shetnev A., Baykov S., Kalinin S., Belova A.,Sharoyko V., Rozhkov A., Zelenkov L., Tarasenko M., Sadykov E., Korsakov M., Krasavin M. 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer. International Journal of Molecular Sciences, 2019, 20(7), 1699. (IF 4.10)

7. Bolotin D.S., Korzhikov-Vlakh V., Sinitsyna E., Yunusova S. N., Suslonov V. V., Shetnev A., Kukushkin V.Y. Biocompatible zinc(II) 8-(dihydroimidazolyl)quinoline complex and its catalytic application for synthesis of poly(L,L-lactide). Journal of Catalysis, 2019, 372, 362–369. (IF 6.759)

8. Krasavin M., Shetnev A., Baykov S., Kalinin, S., Nocentini, A., Sharoyko, V., Poli, G., Tuccinardi, T., Korsakov, M., Tennikova, T. B., Supuran, C. T. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines. Eur. J. Med. Chem., 2019, 168, 301-314. (IF 4.82) 

9. Krasavin, M., Shetnev A., Sharonova T., Baykov S., Kalinin S., Nocentini A., Sharoyko V., Poli G., Tuccinardi T., Presnukhina S., Tennikova T. B., Supuran C. T. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. Eur. J. Med. Chem., 2019, 164, 92-105. (IF 4.82) 

10. Shetnev A., Osipyan A., Baykov S., Sapegin A., Chirkova Z., Korsakov M., Petzer A., Engelbrecht I. and Petzer J. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework. Bioorganic & Medicinal Chemistry Letters, 2019, 29(1), 40-46. (IF 2.44)